{id:37388,date:2019-05-13T00:00:00,date_gmt:2019-05-13T00:00:00,guid:{rendered:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/},modified:2025-10-14T02:47:30,modified_gmt:2025-10-14T02:47:30,slug:una-nuova-terapia-farmacologica-per-gestire-lasma,status:publish,type:post,link:https:\/\/www.hunimed.eu\/it\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/,title:{rendered:Una nuova terapia farmacologica per gestire l&#8217;asma},content:{rendered:<p><img loading=\lazy\ decoding=\async\ class=\size-full wp-image-39672\ src=\https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg\ alt=\\ width=\1254\ height=\836\ \/><\/p>\n<p>L\u2019<strong>asma<\/strong> \u00e8 una <strong>malattia infiammatoria cronica delle vie aeree<\/strong>\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini e gli adulti di et\u00e0 inferiore ai quarantacinque anni che ne sono affetti).\u00a0<\/p>\n<p>Spesso, per\u00f2, i pazienti tendono a sottovalutare la patologia e a non trattarla in maniera continuativa e regolare. Secondo i dati, infatti, solo un paziente su tre segue correttamente le indicazioni e la terapia farmacologica prescritta dal medico, necessarie per stabilizzare la situazione ed evitare l\u2019insorgenza delle crisi.<\/p>\n<p>\u00c8 dimostrato che se una persona asmatica non si cura e continua ad avere degli attacchi, la sua funzione respiratoria diminuisce notevolmente rispetto al decadimento funzionale fisiologico.<\/p>\n<p>&nbsp;<\/p>\n<h3>La strategia per gestire l\u2019asma<\/h3>\n<p>Tosse, respiro sibilante, difficolt\u00e0 a respirare, senso di oppressione al torace, sono i principali <strong>sintomi <\/strong>dell\u2019asma, la cui intensit\u00e0 varia in rapporto all\u2019entit\u00e0 dell\u2019ostruzione bronchiale e al grado della sua percezione da parte del paziente.<\/p>\n<p>Gli attacchi d\u2019asma peggiorano questi sintomi e, di conseguenza, la funzionalit\u00e0 polmonare; per questo motivo \u00e8 di fondamentale importanza <strong>prevenire <\/strong>questi attacchi, attraverso l\u2019adozione di adeguate strategie, comportamentali e farmacologiche, che prevedono la collaborazione tra pazienti e operatori sanitari.<\/p>\n<p>&nbsp;<\/p>\n<h3>Un nuovo modo di affrontare l\u2019asma<\/h3>\n<p>In tema di trattamento dell\u2019asma, i dati di mercato italiani dimostrano come <strong>finora<\/strong> ci sia stata l\u2019erronea tendenza a fare un eccessivo affidamento sui <strong>broncodilatatori beta 2-agonisti a breve durata d&#8217;azione (SABA)<\/strong>, le famose \u201cbombolette blu\u201d, in quanto questi farmaci consentono solo un sollievo temporaneo dei sintomi senza, per\u00f2, agire sull&#8217;infiammazione sottostante. \u00c8 stato evidenziato che i SABA, da soli, non sono in grado di proteggere i pazienti dagli attacchi acuti e il loro uso regolare o frequente porta a un aumento del rischio di riacutizzazioni, con conseguente progressiva modifica della struttura delle vie respiratorie del paziente.<\/p>\n<p>A questo proposito, il dottor<a href=\https:\/\/www.hunimed.eu\/it\/professori\/riccardo-borroni\/canonica-giorgio-walter-2\/\><strong> Giorgio Walter Canonica<\/strong><\/a>, professore di Medicina Respiratoria in <strong>°µÍø½ûÇø University<\/strong> e responsabile del Centro Medicina Personalizzata Asma e Allergologia di °µÍø½ûÇø, ha fatto sapere che <strong>oggi l\u2019asma viene gestita in modo differente <\/strong>rispetto agli ultimi trent\u2019anni, attraverso una nuova terapia farmacologica, raccomandata sia negli adulti sia negli adolescenti, che consente di ridurre sensibilmente gli attacchi gravi.<\/p>\n<p>\u00a0\u201cLe <strong>nuove Linee Guida<\/strong> \u2013 ha precisato l\u2019esperto \u2013 non raccomandano pi\u00f9 il trattamento con i soli SABA, ma piuttosto una <strong>combinazione di corticosteroide inalatorio (Ics) + beta2-agonisti a lunga durata d\u2019azione (LABA)- formoterolo<\/strong>. Quando insorge l\u2019attacco d\u2019asma, lo stimolo infiammatorio non \u00e8 controllato per cui, oltre al broncodilatatore, \u00e8 necessario somministrare l\u2019antinfiammatorio\u201d.<\/p>\n<p>&nbsp;<\/p>\n<h3>La consulenza specialistica gratuita<\/h3>\n<p>Il professor <strong>Canonica<\/strong> ha pi\u00f9 volte ribadito quanto sia importante la costante e giusta <strong>informazione<\/strong> in merito a questa patologia ed \u00e8 per questo che incoraggia a sensibilizzare le persone sull\u2019importanza del controllo.<\/p>\n<p><strong>Dal 3 al 7 giugno 2019<\/strong> prender\u00e0 il via su tutto il territorio nazionale una <strong>campagna di consulenze specialistiche gratuite <\/strong>che offrir\u00e0 ai circa tre milioni di cittadini che soffrono di asma l\u2019opportunit\u00e0 di effettuare una visita di controllo e ricevere informazioni utili, in termini sia di comportamento sia di trattamento, per una migliore gestione della propria malattia, che ha un forte impatto negativo sulla qualit\u00e0 della vita.<\/p>\n<p>L\u2019iniziativa rappresenta un\u2019importante occasione per imparare ad avere un buon controllo dell\u2019asma e ridurre il rischio di sue riacutizzazioni e di conseguenti visite d\u2019emergenza o ricoveri.<\/p>\n,protected:false},excerpt:{rendered:<p>L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini e gli adulti di et\u00e0 inferiore ai quarantacinque anni che ne sono affetti).\u00a0 Spesso, per\u00f2, i pazienti tendono a sottovalutare la patologia e a non trattarla in maniera continuativa e [&hellip;]<\/p>\n,protected:false},author:1,featured_media:17184,comment_status:open,ping_status:open,sticky:false,template:,format:standard,meta:{_acf_changed:false,_kad_blocks_custom_css:,_kad_blocks_head_custom_js:,_kad_blocks_body_custom_js:,_kad_blocks_footer_custom_js:,footnotes:},categories:[2025,2385],tags:[2708,2709,425],class_list:[post-37388,post,type-post,status-publish,format-standard,has-post-thumbnail,hentry,category-scienze-mediche-3-2,category-tutti-5,tag-allergologia-5,tag-asma-5,tag-humanitas-university],acf:[],yoast_head:<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Una nuova terapia farmacologica per gestire l&#039;asma - Hunimed<\/title>\n<meta name=\description\ content=\L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini\ \/>\n<meta name=\robots\ content=\index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\ \/>\n<link rel=\canonical\ href=\https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/\ \/>\n<meta property=\og:locale\ content=\it_IT\ \/>\n<meta property=\og:type\ content=\article\ \/>\n<meta property=\og:title\ content=\Una nuova terapia farmacologica per gestire l&#039;asma - Hunimed\ \/>\n<meta property=\og:description\ content=\L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini\ \/>\n<meta property=\og:url\ content=\https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/\ \/>\n<meta property=\og:site_name\ content=\Hunimed\ \/>\n<meta property=\article:publisher\ content=\https:\/\/www.facebook.com\/Hunimed\/\ \/>\n<meta property=\article:published_time\ content=\2019-05-13T00:00:00+00:00\ \/>\n<meta property=\article:modified_time\ content=\2025-10-14T02:47:30+00:00\ \/>\n<meta property=\og:image\ content=\https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg\ \/>\n\t<meta property=\og:image:width\ content=\1254\ \/>\n\t<meta property=\og:image:height\ content=\836\ \/>\n\t<meta property=\og:image:type\ content=\image\/jpeg\ \/>\n<meta name=\author\ content=\Emicha\ \/>\n<meta name=\twitter:card\ content=\summary_large_image\ \/>\n<meta name=\twitter:label1\ content=\Scritto da\ \/>\n\t<meta name=\twitter:data1\ content=\Emicha\ \/>\n\t<meta name=\twitter:label2\ content=\Tempo di lettura stimato\ \/>\n\t<meta name=\twitter:data2\ content=\3 minuti\ \/>\n<script type=\application\/ld+json\ class=\yoast-schema-graph\>{\@context\:\https:\\\/\\\/schema.org\,\@graph\:[{\@type\:\Article\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#article\,\isPartOf\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/\},\author\:{\name\:\Emicha\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#\\\/schema\\\/person\\\/98ebab45e54332ef43da7a4d1748ca0d\},\headline\:\Una nuova terapia farmacologica per gestire l&#8217;asma\,\datePublished\:\2019-05-13T00:00:00+00:00\,\dateModified\:\2025-10-14T02:47:30+00:00\,\mainEntityOfPage\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/\},\wordCount\:565,\commentCount\:0,\publisher\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#organization\},\image\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#primaryimage\},\thumbnailUrl\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/iStock-854682188.jpg?wsr\,\keywords\:[\Allergologia\,\asma\,\°µÍø½ûÇø University\],\articleSection\:[\Scienze Mediche\,\Tutti\],\inLanguage\:\it-IT\},{\@type\:\WebPage\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/\,\url\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/\,\name\:\Una nuova terapia farmacologica per gestire l'asma - Hunimed\,\isPartOf\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#website\},\primaryImageOfPage\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#primaryimage\},\image\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#primaryimage\},\thumbnailUrl\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/iStock-854682188.jpg?wsr\,\datePublished\:\2019-05-13T00:00:00+00:00\,\dateModified\:\2025-10-14T02:47:30+00:00\,\description\:\L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini\,\breadcrumb\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#breadcrumb\},\inLanguage\:\it-IT\,\potentialAction\:[{\@type\:\ReadAction\,\target\:[\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/\]}]},{\@type\:\ImageObject\,\inLanguage\:\it-IT\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#primaryimage\,\url\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/iStock-854682188.jpg?wsr\,\contentUrl\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/iStock-854682188.jpg?wsr\,\width\:1254,\height\:836},{\@type\:\BreadcrumbList\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/news\\\/una-nuova-terapia-farmacologica-per-gestire-lasma\\\/#breadcrumb\,\itemListElement\:[{\@type\:\ListItem\,\position\:1,\name\:\Home\,\item\:\https:\\\/\\\/www.hunimed.eu\\\/it\\\/\},{\@type\:\ListItem\,\position\:2,\name\:\Una nuova terapia farmacologica per gestire l&#8217;asma\}]},{\@type\:\WebSite\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#website\,\url\:\https:\\\/\\\/www.hunimed.eu\\\/\,\name\:\Hunimed\,\description\:\°µÍø½ûÇø University\,\publisher\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#organization\},\potentialAction\:[{\@type\:\SearchAction\,\target\:{\@type\:\EntryPoint\,\urlTemplate\:\https:\\\/\\\/www.hunimed.eu\\\/?s={search_term_string}\},\query-input\:{\@type\:\PropertyValueSpecification\,\valueRequired\:true,\valueName\:\search_term_string\}}],\inLanguage\:\it-IT\},{\@type\:\Organization\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#organization\,\name\:\°µÍø½ûÇø University\,\url\:\https:\\\/\\\/www.hunimed.eu\\\/\,\logo\:{\@type\:\ImageObject\,\inLanguage\:\it-IT\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\,\url\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Logo.svg?wsr\,\contentUrl\:\https:\\\/\\\/www.hunimed.eu\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Logo.svg?wsr\,\caption\:\°µÍø½ûÇø University\},\image\:{\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\},\sameAs\:[\https:\\\/\\\/www.facebook.com\\\/Hunimed\\\/\,\https:\\\/\\\/www.linkedin.com\\\/school\\\/18280267\\\/admin\\\/\]},{\@type\:\Person\,\@id\:\https:\\\/\\\/www.hunimed.eu\\\/#\\\/schema\\\/person\\\/98ebab45e54332ef43da7a4d1748ca0d\,\name\:\Emicha\,\image\:{\@type\:\ImageObject\,\inLanguage\:\it-IT\,\@id\:\https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g\,\url\:\https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g\,\contentUrl\:\https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g\,\caption\:\Emicha\},\sameAs\:[\https:\\\/\\\/www.hunimed.eu\],\url\:\https:\\\/\\\/www.hunimed.eu\\\/it\\\/news\\\/author\\\/emicha\\\/\}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->,yoast_head_json:{title:Una nuova terapia farmacologica per gestire l'asma - Hunimed,description:L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini,robots:{index:index,follow:follow,max-snippet:max-snippet:-1,max-image-preview:max-image-preview:large,max-video-preview:max-video-preview:-1},canonical:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/,og_locale:it_IT,og_type:article,og_title:Una nuova terapia farmacologica per gestire l'asma - Hunimed,og_description:L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini,og_url:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/,og_site_name:Hunimed,article_publisher:https:\/\/www.facebook.com\/Hunimed\/,article_published_time:2019-05-13T00:00:00+00:00,article_modified_time:2025-10-14T02:47:30+00:00,og_image:[{width:1254,height:836,url:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg,type:image\/jpeg}],author:Emicha,twitter_card:summary_large_image,twitter_misc:{Scritto da:Emicha,Tempo di lettura stimato:3 minuti},schema:{@context:https:\/\/schema.org,@graph:[{@type:Article,@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#article,isPartOf:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/},author:{name:Emicha,@id:https:\/\/www.hunimed.eu\/#\/schema\/person\/98ebab45e54332ef43da7a4d1748ca0d},headline:Una nuova terapia farmacologica per gestire l&#8217;asma,datePublished:2019-05-13T00:00:00+00:00,dateModified:2025-10-14T02:47:30+00:00,mainEntityOfPage:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/},wordCount:565,commentCount:0,publisher:{@id:https:\/\/www.hunimed.eu\/#organization},image:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#primaryimage},thumbnailUrl:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg?wsr,keywords:[Allergologia,asma,°µÍø½ûÇø University],articleSection:[Scienze Mediche,Tutti],inLanguage:it-IT},{@type:WebPage,@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/,url:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/,name:Una nuova terapia farmacologica per gestire l'asma - Hunimed,isPartOf:{@id:https:\/\/www.hunimed.eu\/#website},primaryImageOfPage:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#primaryimage},image:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#primaryimage},thumbnailUrl:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg?wsr,datePublished:2019-05-13T00:00:00+00:00,dateModified:2025-10-14T02:47:30+00:00,description:L\u2019asma \u00e8 una malattia infiammatoria cronica delle vie aeree\u00a0che colpisce circa 300 milioni di persone nel mondo (in Europa sono circa 30 milioni i bambini,breadcrumb:{@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#breadcrumb},inLanguage:it-IT,potentialAction:[{@type:ReadAction,target:[https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/]}]},{@type:ImageObject,inLanguage:it-IT,@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#primaryimage,url:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg?wsr,contentUrl:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188.jpg?wsr,width:1254,height:836},{@type:BreadcrumbList,@id:https:\/\/www.hunimed.eu\/news\/una-nuova-terapia-farmacologica-per-gestire-lasma\/#breadcrumb,itemListElement:[{@type:ListItem,position:1,name:Home,item:https:\/\/www.hunimed.eu\/it\/},{@type:ListItem,position:2,name:Una nuova terapia farmacologica per gestire l&#8217;asma}]},{@type:WebSite,@id:https:\/\/www.hunimed.eu\/#website,url:https:\/\/www.hunimed.eu\/,name:Hunimed,description:°µÍø½ûÇø University,publisher:{@id:https:\/\/www.hunimed.eu\/#organization},potentialAction:[{@type:SearchAction,target:{@type:EntryPoint,urlTemplate:https:\/\/www.hunimed.eu\/?s={search_term_string}},query-input:{@type:PropertyValueSpecification,valueRequired:true,valueName:search_term_string}}],inLanguage:it-IT},{@type:Organization,@id:https:\/\/www.hunimed.eu\/#organization,name:°µÍø½ûÇø University,url:https:\/\/www.hunimed.eu\/,logo:{@type:ImageObject,inLanguage:it-IT,@id:https:\/\/www.hunimed.eu\/#\/schema\/logo\/image\/,url:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/06\/Logo.svg?wsr,contentUrl:https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/06\/Logo.svg?wsr,caption:°µÍø½ûÇø University},image:{@id:https:\/\/www.hunimed.eu\/#\/schema\/logo\/image\/},sameAs:[https:\/\/www.facebook.com\/Hunimed\/,https:\/\/www.linkedin.com\/school\/18280267\/admin\/]},{@type:Person,@id:https:\/\/www.hunimed.eu\/#\/schema\/person\/98ebab45e54332ef43da7a4d1748ca0d,name:Emicha,image:{@type:ImageObject,inLanguage:it-IT,@id:https:\/\/secure.gravatar.com\/avatar\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g,url:https:\/\/secure.gravatar.com\/avatar\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g,contentUrl:https:\/\/secure.gravatar.com\/avatar\/82511d8332a1a463eadc6627f6fc25856d9798af6e6757594c0386d52d1635e8?s=96&d=mm&r=g,caption:Emicha},sameAs:[https:\/\/www.hunimed.eu],url:https:\/\/www.hunimed.eu\/it\/news\/author\/emicha\/}]}},taxonomy_info:{category:[{value:2025,label:Scienze Mediche},{value:2385,label:Tutti}],post_tag:[{value:2708,label:Allergologia},{value:2709,label:asma},{value:425,label:°µÍø½ûÇø University}]},featured_image_src_large:[https:\/\/www.hunimed.eu\/wp-content\/uploads\/2025\/08\/iStock-854682188-1024x683.jpg?wsr,1024,683,true],author_info:{display_name:Emicha,author_link:https:\/\/www.hunimed.eu\/it\/news\/author\/emicha\/},comment_info:,category_info:[{term_id:2025,name:Scienze Mediche,slug:scienze-mediche-3-2,term_group:0,term_taxonomy_id:2025,taxonomy:category,description:,parent:0,count:207,filter:raw,cat_ID:2025,category_count:207,category_description:,cat_name:Scienze Mediche,category_nicename:scienze-mediche-3-2,category_parent:0},{term_id:2385,name:Tutti,slug:tutti-5,term_group:0,term_taxonomy_id:2385,taxonomy:category,description:,parent:0,count:231,filter:raw,cat_ID:2385,category_count:231,category_description:,cat_name:Tutti,category_nicename:tutti-5,category_parent:0}],tag_info:[{term_id:2708,name:Allergologia,slug:allergologia-5,term_group:0,term_taxonomy_id:2708,taxonomy:post_tag,description:,parent:0,count:1,filter:raw},{term_id:2709,name:asma,slug:asma-5,term_group:0,term_taxonomy_id:2709,taxonomy:post_tag,description:,parent:0,count:1,filter:raw},{term_id:425,name:°µÍø½ûÇø University,slug:humanitas-university,term_group:0,term_taxonomy_id:425,taxonomy:post_tag,description:,parent:0,count:152,filter:raw}],_links:{self:[{href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/posts\/37388,targetHints:{allow:[GET]}}],collection:[{href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/posts}],about:[{href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/types\/post}],author:[{embeddable:true,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/users\/1}],replies:[{embeddable:true,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/comments?post=37388}],version-history:[{count:1,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/posts\/37388\/revisions}],predecessor-version:[{id:37389,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/posts\/37388\/revisions\/37389}],wp:featuredmedia:[{embeddable:true,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/media\/17184}],wp:attachment:[{href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/media?parent=37388}],wp:term:[{taxonomy:category,embeddable:true,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/categories?post=37388},{taxonomy:post_tag,embeddable:true,href:https:\/\/www.hunimed.eu\/it\/wp-json\/wp\/v2\/tags?post=37388}],curies:[{name:wp,href:https:\/\/api.w.org\/{rel},templated:true}]}}